Cargando…
Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
The incidence of gastric cancer is increasing year by year. Most gastric cancers are already in the advanced stage with poor prognosis when diagnosed, which means the current treatment is not satisfactory. Angiogenesis is an important link in the occurrence and development of tumors, and there are m...
Autores principales: | Xu, Donghan, Luo, Yehao, Wang, Peng, Li, Jiaxin, Ma, Linrui, Huang, Jie, Zhang, Hao, Yang, Xiaoman, Li, Liqi, Zheng, Yuhong, Fang, Gang, Yan, Peiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295723/ https://www.ncbi.nlm.nih.gov/pubmed/37384288 http://dx.doi.org/10.3389/fonc.2023.1148131 |
Ejemplares similares
-
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020) -
Application and progress of palliative therapy in advanced gastric carcinomas
por: Luo, Xiao-fan, et al.
Publicado: (2023) -
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022) -
Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
por: Yang, Zhengyang, et al.
Publicado: (2022) -
Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
por: Schiffmann, Lars M., et al.
Publicado: (2022)